AnnouncedFiled 9 September 2025
Reunion Neuroscience, Inc. has sold $120M so far
Reunion Neuroscience, Inc., a pharmaceuticals company based in Morristown, NJ, has sold $120M so far in its equity round, according to a filing dated 9 September 2025.
Announced on 2 May 2024, 495 days before the filing. reunionneuro.com ↗
- Filed
- 9 September 2025
- First filed
- 25 January 2024
- Round
- Equity round (amended filing)
- Amount sold
- $120M
- Offering size
- $120M
- Investors so far
- 9
- Based in
- Morristown, NJ
- Website
- reunionneuro.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 96% of the 1,404 tracked raises with an amount filed in 2025.
Reunion Neuroscience, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 9 Sep 2025 | Amended filing | $120M | This raise |
| 5 May 2025 | Amended filing | $68.9M | This raise |
| 6 May 2024 | Amended filing | $33.7M | This raise |
| 25 Jan 2024 | New filing | $16.9M | This raise |
More with MPM BioVentures on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.